Utilization patterns of glucagon-like peptide-1 receptor agonists in patients with type 2 diabetes mellitus in Germany: a retrospective cohort study
One of the most interesting points was how tirzepatide works differently from GLP-1 treatment alone
Craig Koniver, a family medicine physician in Charleston, South Carolina, said he has all 200 of his patients who are taking the GlP-1s for weight loss on microdoses, reporting excellent results with minimal side effects
Stiffness that gets better with light exercise leads to loss of function or extreme weakness, which requires reporting
The fiber in avocados can slow digestion, leading to a more gradual release of glucose into the bloodstream
Back Creutzfeldt, W (15 June 2005) 'The [pre-] history of the incretin concept', Regulatory Peptides , 128/2, 87-91